ADMA Biologics hits 10-month high as Asceniv drives Q3 beat

ADMA Biologics (ADMA) stock jumps as the company posts better-than-expected financials for Q3 2026. Read more here.

CryptoAlerta — análise de criptomoedas e mercado em tempo real